1. Home
  2. VBNK vs EVO Comparison

VBNK vs EVO Comparison

Compare VBNK & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo VersaBank

VBNK

VersaBank

HOLD

Current Price

$22.79

Market Cap

622.7M

Sector

Finance

ML Signal

HOLD

Logo Evotec SE

EVO

Evotec SE

HOLD

Current Price

$1.54

Market Cap

568.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VBNK
EVO
Founded
1980
1993
Country
Canada
Germany
Employees
N/A
4553
Industry
Commercial Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
622.7M
568.6M
IPO Year
2016
2007

Fundamental Metrics

Financial Performance
Metric
VBNK
EVO
Price
$22.79
$1.54
Analyst Decision
Buy
Strong Buy
Analyst Count
2
1
Target Price
$13.00
$7.00
AVG Volume (30 Days)
104.1K
108.8K
Earning Date
06-03-2026
04-08-2026
Dividend Yield
0.41%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$30.02
$1.37
Revenue Next Year
$27.30
$10.05
P/E Ratio
$25.91
N/A
Revenue Growth
N/A
N/A
52 Week Low
$11.25
$1.57
52 Week High
$24.42
$4.27

Technical Indicators

Market Signals
Indicator
VBNK
EVO
Relative Strength Index (RSI) 62.48 26.98
Support Level $17.65 N/A
Resistance Level $24.42 $1.97
Average True Range (ATR) 0.86 0.05
MACD 0.19 -0.02
Stochastic Oscillator 84.16 4.88

Price Performance

Historical Comparison
VBNK
EVO

About VBNK VersaBank

VersaBank is a Schedule I Canadian bank that provides mainly commercial lending and banking services to select niche markets in Canada and the United States. Its products and services include credit assets, deposits, and cybersecurity services through its wholly owned subsidiary. The bank operates through four segments: Digital Banking Canada and Digital Banking USA, both using a business-to-business model with proprietary financial technology to serve underserved markets; DRTC, which provides cybersecurity services and banking and financial technology development; and Digital Meteor, which owns proprietary technology supporting next-generation digital assets, including Real Bank Deposit Tokens (RBDTs). The majority of revenue comes from Digital Banking.

About EVO Evotec SE

Evotec SE is a life science company focused on developing pharmaceutical products through standalone services, integrated R&D programs, and strategic partnerships with pharmaceutical and biotechnology companies, academic institutions, and other partners. It operates across drug discovery, preclinical development, and manufacturing, with expertise in areas including oncology, central nervous system, cardiovascular-renal, immune and inflammatory, infectious, and other diseases. The Company generates revenue through fee-for-service and FTE-based services, milestones, and royalties, and equity ownership in biotechnology and academic projects. It operates through the Shared R&D and Discovery & Preclinical Development (D&PD) segments, with the majority of revenue generated from the USA.

Share on Social Networks: